Skip to main content
Erschienen in: Rheumatology International 3/2012

01.03.2012 | Original Article

Nine cases of Alkaptonuria in one family in southern Jordan

verfasst von: Mohammed Al-sbou, Nesrin Mwafi

Erschienen in: Rheumatology International | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Alkaptonuria is a rare autosomal recessive metabolic disorder characterized by a deficiency of homogentisate 1,2-dioxygenase (HGO) in the liver. This results in excretion of large quantities of homogentisic acid (HGA) (also called alkapton) in the urine and a slowly progressive deposition of homogentisic acid and its oxidative product in connective tissues. Clinical characteristic features of alkaptonuria are darkening of urine, bluish-dark pigmentation of connective tissues (ochronosis) and arthritis of large joints and spine. Cardiovascular and genitourinary systems may also be affected. In this report, we present the initial results of screening family members with history of alkaptonuria in southern region of Jordan. We present 9 cases of alkaptonuria (two males and seven females) in one Jordanian family. The history, signs and symptoms, diagnostic techniques and treatment options of alkaptonuria are reviewed in this article.
Literatur
1.
Zurück zum Zitat Stenn FF, Milgram JW, Lee SL, Weigand RJ, Veis A (1977) Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy. Science 197(4303):566–568PubMedCrossRef Stenn FF, Milgram JW, Lee SL, Weigand RJ, Veis A (1977) Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy. Science 197(4303):566–568PubMedCrossRef
2.
Zurück zum Zitat Idem (1908) The Croonian lectures on inborn errors of metabolism. Lecture II. Alkaptonuria. Lancet 2:73–79 Idem (1908) The Croonian lectures on inborn errors of metabolism. Lecture II. Alkaptonuria. Lancet 2:73–79
3.
Zurück zum Zitat La Du BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230(1):251–260PubMed La Du BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230(1):251–260PubMed
4.
Zurück zum Zitat Fernandez-Canon JM, Granadino B, Beltran-Valero de Bernabe D, Renedo M, Fernandez-Ruiz E, Penalva MA et al (1996) The molecular basis of alkaptonuria. Nat Genet 14(1):19–24PubMedCrossRef Fernandez-Canon JM, Granadino B, Beltran-Valero de Bernabe D, Renedo M, Fernandez-Ruiz E, Penalva MA et al (1996) The molecular basis of alkaptonuria. Nat Genet 14(1):19–24PubMedCrossRef
5.
Zurück zum Zitat Keller JM, Macaulay W, Nercessian OA, Jaffe IA (2005) New developments in ochronosis: review of the literature. Rheumatol Int 25(2):81–85PubMedCrossRef Keller JM, Macaulay W, Nercessian OA, Jaffe IA (2005) New developments in ochronosis: review of the literature. Rheumatol Int 25(2):81–85PubMedCrossRef
6.
Zurück zum Zitat Castagna A, Giombini A, Vinanti G, Massazza G, Pigozzi F (2006) Arthroscopic treatment of shoulder ochronotic arthropathy: a case report and review of literature. Knee Surg Sports Traumatol Arthrosc 14(2):176–181PubMedCrossRef Castagna A, Giombini A, Vinanti G, Massazza G, Pigozzi F (2006) Arthroscopic treatment of shoulder ochronotic arthropathy: a case report and review of literature. Knee Surg Sports Traumatol Arthrosc 14(2):176–181PubMedCrossRef
7.
Zurück zum Zitat Wagner LR, Knott JL, Machaffie RA, Walsh JR (1960) Clinical and pathological findings in ochronosis. J Clin Pathol 13(1):22–26PubMedCrossRef Wagner LR, Knott JL, Machaffie RA, Walsh JR (1960) Clinical and pathological findings in ochronosis. J Clin Pathol 13(1):22–26PubMedCrossRef
8.
Zurück zum Zitat Ladjouze-Rezig A, Rodriguez de Cordoba S, Aquaron R (2006) Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies—a case study of 14 patients in 11 families. Joint Bone Spine 73(3):284–292PubMedCrossRef Ladjouze-Rezig A, Rodriguez de Cordoba S, Aquaron R (2006) Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies—a case study of 14 patients in 11 families. Joint Bone Spine 73(3):284–292PubMedCrossRef
9.
Zurück zum Zitat Cetinus E, Cever I, Kural C, Erturk H, Akyildiz M (2005) Ochronotic arthritis: case reports and review of the literature. Rheumatol Int 25(6):465–468PubMedCrossRef Cetinus E, Cever I, Kural C, Erturk H, Akyildiz M (2005) Ochronotic arthritis: case reports and review of the literature. Rheumatol Int 25(6):465–468PubMedCrossRef
10.
Zurück zum Zitat Ffolkes LV, Brull D, Krywawych S, Hayward M, Hughes SE (2007) Aortic stenosis in cardiovascular ochronosis. J Clin Pathol 60(1):92–93PubMedCrossRef Ffolkes LV, Brull D, Krywawych S, Hayward M, Hughes SE (2007) Aortic stenosis in cardiovascular ochronosis. J Clin Pathol 60(1):92–93PubMedCrossRef
11.
Zurück zum Zitat Fisher AA, Davis MW (2004) Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review. Clin Med Res 2(4):209–215PubMedCrossRef Fisher AA, Davis MW (2004) Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review. Clin Med Res 2(4):209–215PubMedCrossRef
12.
Zurück zum Zitat Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL et al (2002) Natural history of alkaptonuria. N Engl J Med 347(26):2111–2121PubMedCrossRef Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD, Fitzpatrick DL et al (2002) Natural history of alkaptonuria. N Engl J Med 347(26):2111–2121PubMedCrossRef
13.
Zurück zum Zitat Raaijmaakers M, Steenbrugge F, Dierickx C (2008) Ochronosis, arthroscopy of a black knee: a case report and review of the literature. Knee Surg Sports Traumatol Arthrosc 16(2):182–184PubMedCrossRef Raaijmaakers M, Steenbrugge F, Dierickx C (2008) Ochronosis, arthroscopy of a black knee: a case report and review of the literature. Knee Surg Sports Traumatol Arthrosc 16(2):182–184PubMedCrossRef
14.
Zurück zum Zitat Scriver CR (2008) Garrod’s Croonian Lectures (1908) and the charter ‘Inborn Errors of Metabolism’: albinism, alkaptonuria, cystinuria, and pentosuria at age 100 in 2008. J Inherit Metab Dis 31(5):580–598PubMedCrossRef Scriver CR (2008) Garrod’s Croonian Lectures (1908) and the charter ‘Inborn Errors of Metabolism’: albinism, alkaptonuria, cystinuria, and pentosuria at age 100 in 2008. J Inherit Metab Dis 31(5):580–598PubMedCrossRef
15.
Zurück zum Zitat Srsen S, Cisarik F, Pasztor L, Harmecko L (1978) Alkaptonuria in the Trencin district of Czechoslovakia. Am J Med Genet 2(2):159–166PubMedCrossRef Srsen S, Cisarik F, Pasztor L, Harmecko L (1978) Alkaptonuria in the Trencin district of Czechoslovakia. Am J Med Genet 2(2):159–166PubMedCrossRef
16.
Zurück zum Zitat Milch RA (1960) Studies of alcaptonuria: inheritance of 47 cases in eight highly inter-related Dominican kindreds. Am J Hum Genet 12(1):76–85PubMed Milch RA (1960) Studies of alcaptonuria: inheritance of 47 cases in eight highly inter-related Dominican kindreds. Am J Hum Genet 12(1):76–85PubMed
17.
Zurück zum Zitat El-Khushman HM (2007) Clinical Quiz. A 69-year-old man with a thick dark pigmentation on his hands, and low back pain. Saudi Med J 28(11):1761–1762PubMed El-Khushman HM (2007) Clinical Quiz. A 69-year-old man with a thick dark pigmentation on his hands, and low back pain. Saudi Med J 28(11):1761–1762PubMed
18.
Zurück zum Zitat Spencer JM, Gibbons CL, Sharp RJ, Carr AJ, Athanasou NA (2004) Arthroplasty for ochronotic arthritis: no failure of 11 replacements in 3 patients followed 6–12 years. Acta Orthop Scand 75(3):355–358PubMedCrossRef Spencer JM, Gibbons CL, Sharp RJ, Carr AJ, Athanasou NA (2004) Arthroplasty for ochronotic arthritis: no failure of 11 replacements in 3 patients followed 6–12 years. Acta Orthop Scand 75(3):355–358PubMedCrossRef
19.
Zurück zum Zitat Morava E, Kosztolanyi G, Engelke UF, Wevers RA (2003) Reversal of clinical symptoms and radiographic abnormalities with protein restriction and ascorbic acid in alkaptonuria. Ann Clin Biochem 40(Pt 1):108–111PubMedCrossRef Morava E, Kosztolanyi G, Engelke UF, Wevers RA (2003) Reversal of clinical symptoms and radiographic abnormalities with protein restriction and ascorbic acid in alkaptonuria. Ann Clin Biochem 40(Pt 1):108–111PubMedCrossRef
20.
Zurück zum Zitat Mayatepek E, Kallas K, Anninos A, Muller E (1998) Effects of ascorbic acid and low-protein diet in alkaptonuria. Eur J Pediatr 157(10):867–868PubMedCrossRef Mayatepek E, Kallas K, Anninos A, Muller E (1998) Effects of ascorbic acid and low-protein diet in alkaptonuria. Eur J Pediatr 157(10):867–868PubMedCrossRef
21.
Zurück zum Zitat Santra S, Baumann U (2008) Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1. Expert Opin Pharmacother 9(7):1229–1236PubMedCrossRef Santra S, Baumann U (2008) Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1. Expert Opin Pharmacother 9(7):1229–1236PubMedCrossRef
22.
Zurück zum Zitat Suzuki Y, Oda K, Yoshikawa Y, Maeda Y, Suzuki T (1999) A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria. J Hum Genet 44(2):79–84PubMedCrossRef Suzuki Y, Oda K, Yoshikawa Y, Maeda Y, Suzuki T (1999) A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria. J Hum Genet 44(2):79–84PubMedCrossRef
23.
Zurück zum Zitat Suwannarat P, O’Brien K, Perry MB, Sebring N, Bernardini I, Kaiser-Kupfer MI et al (2005) Use of nitisinone in patients with alkaptonuria. Metabolism 54(6):719–728PubMedCrossRef Suwannarat P, O’Brien K, Perry MB, Sebring N, Bernardini I, Kaiser-Kupfer MI et al (2005) Use of nitisinone in patients with alkaptonuria. Metabolism 54(6):719–728PubMedCrossRef
24.
Zurück zum Zitat Lock EA, Ellis MK, Gaskin P, Robinson M, Auton TR, Provan WM et al (1998) From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1, 3-cyclohexanedione (NTBC), its toxicology and development as a drug. J Inherit Metab Dis 21(5):498–506PubMedCrossRef Lock EA, Ellis MK, Gaskin P, Robinson M, Auton TR, Provan WM et al (1998) From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1, 3-cyclohexanedione (NTBC), its toxicology and development as a drug. J Inherit Metab Dis 21(5):498–506PubMedCrossRef
Metadaten
Titel
Nine cases of Alkaptonuria in one family in southern Jordan
verfasst von
Mohammed Al-sbou
Nesrin Mwafi
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 3/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1701-1

Weitere Artikel der Ausgabe 3/2012

Rheumatology International 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.